How many insider declarations has Pfizer Inc filed?

Pfizer Inc has filed 3 public insider declarations with SEC (Form 4).

What is Pfizer Inc's role?

Pfizer Inc's reported role is not specified by the regulator across the filings.

Which companies does Pfizer Inc report trades for?

Pfizer Inc reports trades for 2 companies, including Pyxis Oncology, Inc..

What is Pfizer Inc's declared buy vs sell volume?

Across the available history, declared buys total 9.4M€ and disposals 0.

← Executives ★ Sign in to follow

PI

Pfizer Inc

·SEC (Form 4)

Pyxis Oncology, Inc.Cerevel Therapeutics Holdings, Inc.

累计流向

0

申报总数

0

公司

€942万

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+20.4%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Browse the complete record of transactions filed by Pfizer Inc. Officer active across 2 companies, notably Pyxis Oncology, Inc.. In total, 3 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €9.4m. Activity tracked since 17 March 2023. The latest transaction was disclosed on 1 August 2024 (U). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Pfizer Inc

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Pyxis Oncology, Inc. (US)Cerevel Therapeutics Holdings, Inc. (US)

申报3 总计

●

PFIZER INC

高管2024年8月1日Cerevel Therapeutics Holdings, Inc.

US$12亿10SEC ↗

27,349,211 股@ US$45.00100.0% 占其流量Common StockSEC:0000078003-24-000169:0

▲

PFIZER INC

高管2023年3月17日Pyxis Oncology, Inc.

US$500万0SEC ↗

1,811,594 股@ US$2.7650.0% 占其流量Common Stock, $0.001 par value per shareSEC:0000078003-23-000052:0

标准退出：2023年6月15日 (T+90)

▲

PFIZER INC

高管2023年3月17日Pyxis Oncology, Inc.

US$500万11SEC ↗

1,811,594 股@ US$2.7650.0% 占其流量Common Stock, $0.001 par value per shareSEC:0000078003-23-000050:0

标准退出：2023年6月15日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

PI

Pfizer Inc

·SEC (Form 4)

Pyxis Oncology, Inc.Cerevel Therapeutics Holdings, Inc.

累计流向

0

申报总数

0

公司

€942万

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

T+90 胜率

100%

T+90 平均收益

+20.4%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Browse the complete record of transactions filed by Pfizer Inc. Officer active across 2 companies, notably Pyxis Oncology, Inc.. In total, 3 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €9.4m. Activity tracked since 17 March 2023. The latest transaction was disclosed on 1 August 2024 (U). Regulator: SEC (Form 4). All data is accessible without signup.